Literature DB >> 19582405

Antigen processing and presentation in multiple sclerosis.

Christina Stoeckle1, Eva Tolosa.   

Abstract

CD4(+) T cells play a central role in the pathogenesis of multiple sclerosis (MS). Generation, activation and effector function of these cells crucially depends on their interaction with MHC II-peptide complexes displayed by antigen presenting cells (APC). Processing and presentation of self antigens by different APC therefore influences the disease course at all stages. Selection by thymic APC leads to the generation of autoreactive T cells, which can be activated by peripheral APC. Reactivation by central nervous system APC leads to the initiation of the inflammatory response resulting in demyelination. In this review we will focus on how MHC class II antigenic epitopes are created by different APC from the thymus, the periphery and from the brain, and will discuss the relevance of the balance between creation and destruction of such epitopes in the context of MS. A solid understanding of these processes offers the possibility for designing future therapeutic strategies.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 19582405     DOI: 10.1007/400_2009_22

Source DB:  PubMed          Journal:  Results Probl Cell Differ        ISSN: 0080-1844


  7 in total

Review 1.  Immune modulating peptides for the treatment and suppression of multiple sclerosis.

Authors:  Ahmed H Badawi; Teruna J Siahaan
Journal:  Clin Immunol       Date:  2012-06-05       Impact factor: 3.969

Review 2.  Do post-translational beta cell protein modifications trigger type 1 diabetes?

Authors:  Joachim Størling; Anne Julie Overgaard; Caroline Anna Brorsson; Francesco Piva; Claus Heiner Bang-Berthelsen; Claus Haase; Jørn Nerup; Flemming Pociot
Journal:  Diabetologia       Date:  2013-09-19       Impact factor: 10.122

Review 3.  Cathepsin G: roles in antigen presentation and beyond.

Authors:  Timo Burster; Henriette Macmillan; Tieying Hou; Bernhard O Boehm; Elizabeth D Mellins
Journal:  Mol Immunol       Date:  2009-11-11       Impact factor: 4.407

4.  Scavenger Receptor A Mediates the Clearance and Immunological Screening of MDA-Modified Antigen by M2-Type Macrophages.

Authors:  Andreas Warnecke; Sonja Abele; Sravani Musunuri; Jonas Bergquist; Robert A Harris
Journal:  Neuromolecular Med       Date:  2017-08-21       Impact factor: 3.843

5.  Predicting CD4 T-cell epitopes based on antigen cleavage, MHCII presentation, and TCR recognition.

Authors:  Dina Schneidman-Duhovny; Natalia Khuri; Guang Qiang Dong; Michael B Winter; Eric Shifrut; Nir Friedman; Charles S Craik; Kathleen P Pratt; Pedro Paz; Fred Aswad; Andrej Sali
Journal:  PLoS One       Date:  2018-11-06       Impact factor: 3.240

6.  Transcriptomic Analysis of Peripheral Monocytes upon Fingolimod Treatment in Relapsing Remitting Multiple Sclerosis Patients.

Authors:  G Sferruzza; F Clarelli; E Mascia; L Ferrè; L Ottoboni; M Sorosina; S Santoro; L Moiola; V Martinelli; G Comi; F Martinelli Boneschi; M Filippi; P Provero; Federica Esposito
Journal:  Mol Neurobiol       Date:  2021-06-28       Impact factor: 5.590

Review 7.  Salivary biomarkers for the diagnosis and monitoring of neurological diseases.

Authors:  Raymond Farah; Hayat Haraty; Ziad Salame; Youssef Fares; David M Ojcius; Najwane Said Sadier
Journal:  Biomed J       Date:  2018-05-10       Impact factor: 4.910

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.